biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	03C7FAD7-A7D5-484A-B84C-CC64F7FA5E86
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BD-A3EP-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BD-A3EP-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BD-A3EP-01A
biospecimen__bio__biospecimen_barcode_bottom	0118957423
biospecimen__bio__day_of_creation	11
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-BD-A3EP.4560D451-6F7E-4F3F-8AF7-F393DB000ABD.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-BD-A3EP
biospecimen__shared__patient_id	A3EP
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	6328BEF7-34BE-4105-BA7E-5197436CF209
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.4
clinical__chol_lihc_shared__albumin_result_specified_value	3.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.3
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	20
clinical__chol_lihc_shared__fetoprotein_outcome_value	17
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.8
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	156
clinical__chol_lihc_shared__platelet_result_upper_limit	369
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.5
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	75
clinical__clin_shared__bcr_followup_barcode	TCGA-BD-A3EP-F68680
clinical__clin_shared__bcr_followup_uuid	57BB3CF4-9602-4E0D-B75A-8FB7C4E4FAD6
clinical__clin_shared__cancer_first_degree_relative	0
clinical__clin_shared__day_of_form_completion	10
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	333
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	f1b1bc66-62cd-47c1-9c18-2ada967681ed
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BD-A3EP-01A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	6754ef76-cd93-4add-b2a9-3ccd0af71b20
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.75
gdc__analytes__analyte_id	7708b942-8def-452b-9252-317ed1b660fd
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	de302b98-250d-42fe-9945-11e1b2bbd3c6
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	a6643770-d005-5be6-a1cb-fda458e647cc
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1935
gdc__diagnoses__age_at_diagnosis	27756
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-27756.0
gdc__diagnoses__days_to_last_follow_up	409.0
gdc__diagnoses__diagnosis_id	10597541-ae09-5bab-843d-f721dfc42b5c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	25.155895691609977
gdc__exposures__exposure_id	c6675c30-aa51-514f-8b32-8ba472b6b60b
gdc__exposures__height	168.0
gdc__exposures__weight	71.0
gdc__file_id	d2cc659e-1220-4bc7-a049-5e97c1d53ed1
gdc__file_name	7f1e1a91-aa48-4fdb-bb19-cbc09dd557b3.mirbase21.mirnas.quantification.txt
gdc__file_size	50438
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	b99b65dd2610f8f7a73cddf5397ea8a5
gdc__portions__is_ffpe	false
gdc__portions__portion_id	9cfaf784-5ff1-4356-a857-7f3b77dc0565
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	398
gdc__samples__initial_weight	140.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	4560D451-6F7E-4F3F-8AF7-F393DB000ABD
gdc__samples__sample_id	553dfa2d-c496-4982-8ba1-32d5054864be
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	ffd96529-3000-4e1b-8162-b3ca896a6e5b
gdc__submitter_id	mirna_swap_dr11_371_MirnaExpressionf4e8beb7-fd94-434a-8c33-1f6c86e83c9b_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BD
gdc__tissue_source_site__name	University of Pittsburgh
gdc__tissue_source_site__tissue_source_site_id	86f2ecb2-6c8a-51da-943d-4acb6d72576d
gdc__treatments__treatment_id	47b407a1-18eb-5505-b45f-0ccf1a6bbe10
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:12:01.621+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f1b1bc66-62cd-47c1-9c18-2ada967681ed-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f1b1bc66-62cd-47c1-9c18-2ada967681ed-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129809
manually_curated__local_md5	d5b46fe759afaf7aedf155e1cc6130f0
manually_curated__opengdc_download_date	2018-10-16T17:13:12.000109+02:00
manually_curated__opengdc_file_md5	7c1e8dc32585b79960900371ba0607eb
manually_curated__opengdc_file_size	50437
manually_curated__opengdc_id	f1b1bc66-62cd-47c1-9c18-2ada967681ed-meq
manually_curated__origin_file_size	129809
manually_curated__origin_last_modified_date	Tue Oct 16 17:42:00 CEST 2018
manually_curated__origin_md5	d5b46fe759afaf7aedf155e1cc6130f0
manually_curated__tissue_status	tumoral
